Insider Selling: Mednax COO Sells 3,162 Shares of Stock (MD)
Mednax (NYSE:MD) COO William Hawk sold 3,162 shares of the stock on the open market in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $100.62, for a total transaction of $318,160.44. Following the transaction, the chief operating officer now directly owns 8,485 shares in the company. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
A number of analysts have recently weighed in on MD shares. Analysts at Credit Suisse raised their price target on shares of Mednax (NYSE:MD) from $90.00 to $97.00 in a research note to investors on Thursday, August 1st. They now have a “neutral” rating on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of Mednax (NYSE:MD) from $100.00 to $112.00 in a research note to investors on Wednesday, July 31st. They now have an “overweight” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Mednax (NYSE:MD) in a research note to investors on Monday, July 8th. They set a “market perform” rating on the stock. They noted that the move was a valuation call.
Seven analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $94.89.
Mednax (NYSE:MD) traded up 0.36% on Thursday, hitting $101.22. 265,843 shares of the company’s stock traded hands. Mednax has a one year low of $67.86 and a one year high of $100.97. The stock has a 50-day moving average of $97.98 and a 200-day moving average of $91.69. The company has a market cap of $5.016 billion and a price-to-earnings ratio of 19.71.
Mednax (NYSE:MD) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.01. The company had revenue of $529.18 million for the quarter, compared to the consensus estimate of $533.39 million. During the same quarter in the prior year, the company posted $1.22 earnings per share. The company’s quarterly revenue was up 17.7% on a year-over-year basis. Analysts expect that Mednax will post $5.46 EPS for the current fiscal year.
MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.